Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 399-411

  Shoji, Mamoru ^a,b   Hancock, Wayne W ^c,d,k   Abe, Keisuke ^a,b   Micko, Cornelia ^a,b   Casper, Katherine A ^a,b   Baine, Rosalie M ^a   Wilcox, Josiah N ^b   Danave, Indrani ^a,b   Dillehay, Dirck L ^b   Matthews, Eileen ^c   Contrino, Josephine ^c   Morrissey, James H ^e   Gordon, Stuart ^f   Edgington, Thomas S ^g   Kudryk, Bohdan ^h   Kreutzer, Donald L ^c   Rickles, Frederick R ^a,b,c,i,j  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d HARTFORD HOSPITAL   (United States)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h NEW YORK BLOOD CENTER   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; CANCER PROCOAGULANT; CYSTEINE PROTEINASE; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; THROMBIN; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIBODY LABELING; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031882775     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Trousseau A: Phlegmasia alba dolens. Clin Med Hôtel-Dieu Paris. 1865, 3:654-712
2. Billroth T: Lectures on Surgical Pathology and Therapeutics, translated from ed 8. London, The New Sydenham Society, 1878
3. Dvorak HF: Abnormalities of hemostasis in malignant disease. Hemostasis and Thrombosis. Edited by Colman RW, Hirsh J, Marder VJ, Salzman EW. Philadelphia, JB Lippincott, 1994, pp 1238-1254
4. Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983, 62:14-31
5. Rickles FR, Edwards RL: Leukocytes and tumor cells in thrombosis. Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Philadelphia, JB Lippincott, 1994, pp 1164-1179
6. Rickles FR, Hancock WW, Edwards RL, Zacharski LR: Antimetastatic agents. I. The role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment. Semin Hematol Thromb 1988, 14:88-94
7. O'Meara RAQ: Coagulative properties of cancers. Irish J Med Sci 1958, 394:474-479
8. Nagy JA, Braun LF, Senger DR, Lanit N, Water LVD, Dvorak AM, Dvorak HF: Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1988, 948:305-326
9. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039
11. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990, 172:1535-1545
12. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D: Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989, 169:1977-1991
13. Contrino J, Goralnick S, Qi J, Hair G, Rickles FR, Kreutzer DL: Fibrin induction of tissue factor expression in human vascular endothelial cells. Circulation 1997, 96:605-613
14. Walz DA, Fenton JW: The role of thrombin in tumor cell metastasis. Invasion Metastasis 1994-1995, 14:303-308
15. Qi J, Kreutzer DL: Fibrin activation of endothelial cells: induction of IL-8 expression. J Immunol 1995, 155:867-876
16. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994, 94:1320-1327
17. Edwards RL, Morgan DL, Rickles FR: Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1990, 63:133-138
18. Edwards RL, Silver J, Rickles FR: Human tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1993, 69:205-213
19. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S: Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990, 76:1-16
20. Van de Water L, Tracy PB, Aronson D, Mann KG, Dvorak HF: Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res 1985, 45:5521-5525
21. Bona R, Matthews E, Patel D, Carta C, Hancock WW, Rickles FR: Functional and immunologic characterization of human tumor procoagulants. Clin Res 1989, 17:465
22. Contrino J, Hair GA, Kreutzer DL, Rickles FR: In situ detection of the expression of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 1996, 2:209-215
23. 2-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 1983, 20:1191-1200
24. 2-terminal fragments region of fibrin. Mol Immunol 1984, 21:89-94
25. Kudryk BJ, Grossman ZD, McAfee JG, Rosebrough SF: Monoclonal antibodies as probes for fibrin(ogen) proteolysis. Monoclonal Antibodies in Immunoscintigraphy. Edited by Chatal J-F. Boca Raton, FL, CRC Press, 1989, 365-398
26. Hogg N: Human monocytes are associated with the formation of fibrin. J Exp Med 1983, 157:473-479
27. Morrissey JH, Fair DS, Edgington TS: Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 1988, 52: 247-261
28. Ruf W, Edgington TS: An anti-tissue factor monoclonal antibody which inhibits TF · VIIa complex is a potent anticoagulant in plasma. Thromb Haemost 1991, 66:529-533
29. Ewan VA, Cieplinski W, Hancock WW, Goldschneider I, Boyd AW, Rickles FR: Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity. J Immunol 1986, 136:2408-2415
30. Hair GA, Padula S, Zeff R, Schmeizl M, Contrino J, Kreutzer DL, de Moerloose P, Boyd AW, Stanley I, Burgess AW, Rickles FR: Tissue factor expression in human leukemic cells. Leuk Res 1996, 20:1-11
31. Gordon SG, Cross BA: An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Cancer Res 1990, 50:6229-6234
32. Hancock WW, Rickles FR, Ewan VA, Atkins RC: Immunohistological studies with A1-3, a monoclonal antibody to activated human monocytes and macrophages. J Immunol 1986, 136:2416-2424
33. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissue: implications for disorders of hemostasis and thrombosis. Am J Pathol 1989, 134:1087-1097
34. Hancock WW, Atkins RC: Immunohistological studies with monoclonal antibodies. Methods Enzymol 1986, 121:828-848
35. Hancock WW, Gee D, de Moerloose PK, Rickles FR, Ewan VA, Atkins RC: Immunohistological analysis of serial biopsies taken during human renal allograft rejection: changing profile of infiltrating cells and involvement of the coagulation system. Transplantation 1985, 39: 430-438
36. Contrino J, Hair GA, Schmeizl MA, Rickles FR, Kreutzer DL: In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol 1994, 145:1315-1322
37. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D: Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988, 82:1134-1143
38. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989, 86:2839-2843
39. Wilcox JN: Fundamental principles of in situ hybridization. J Histochem Cytochem 1993, 41:1725-1733
40. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 1984, 12:7035-7056
41. Folkman J: Tumor angiogenesis and tissue factor. Nature Med 1996, 2:167-168
42. Edwards RL, Rickles FR, Bobrove AM: Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood 1979, 54:359-370
43. Gregory SA, Edgington TS: Tissue factor induction in human monocytes: two distinct mechanisms displayed by different alloantigen responsive T cell clones. J Clin Invest 1985, 76:2440-2445
44. Gregory SA, Morrissey JH, Edgington TS: Regulation of tissue factor gene expression in the human monocyte procoagulant response to endotoxin. Mol Cell Biol 1989, 9:2752-2755
45. Geczy CL, Meyer PA: Leukocyte procoagulant activity in man: an in vitro correlate of delayed type hypersensitivity. J Immunol 1982, 128: 2457-2463
46. Edwards RL, Ewan VA, Rickles FR: Macrophage procoagulants, fibrin deposition, and the inflammatory response. The Reticuloendothelial System. Edited by Phillips SM, Escobar MR. New York, Plenum, 1986, pp 233-266
47. Edwards RL, Rickles FR, Cronlund M: Abnormalities of blood coagulation in patients with cancer: monocyte tissue factor generation and fibrinopeptide A levels. J Lab Clin Med 1981, 98:917-928
48. Morgan D, Edwards RL, Rickles FR: Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients. Haemostasis 1988, 18:55-65
49. Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, Mantovani A, Donati MB: Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 1983, 62:271-273
50. Semeraro N, De Lucia O, Lattanzio A, Montermurro P, Giordano D, Loizzi M, Carpagnano F: Procoagulant activity of human alveolar macrophages: different expression in patients with lung cancer. Int J Cancer 1986, 37:525-529
51. Semeraro N, Montemurro P, Conese M, Biordano D, Steela M, Restaino A, Kagnazzo G, Colucci M: Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 1990, 45:251-254
52. Rickles FR, Hancock WW: Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors and inflammatory cells and their soluble mediators: Potential for therapeutic interventions. Semin Hematol Thromb 1988, 14:126-132
53. Gregory SA, Kornbluth RS, Helin H, Remold HG, Edgington TS: Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol 1986, 137:3231-3239
54. Wojtukiewcz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM, Stump DC: Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer 1990, 65:481-485
55. Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG: Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res 1986, 46:6471-6474
56. Alessio MG, Falanga A, Consonni R, Bassen R, Minetti B, Donati MB, Barbui T: Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990, 45:78-81
57. Falanga A, Alessio MG, Donati MB, Barbui T: A new procoagulant in acute leukemia. Blood 1988, 71:870-875
58. Grignani G, Falanga A, Pachiarini L, Alessio MG, Zucchella M, Fratino P, Donati MB: Human breast and colon carcinomas express cysteine protease activities with platelet aggregating and procoagulant properties. Int J Cancer 1988, 42:554-557
59. Shoji M, Abe K, Dillehay D, Casper K, Micko C, Danave I, Nawroth PP, Rickles FR: Tissue factor (TF) regulates the expression of vascular endothelial growth factor (VEGF) in vitro and angiogenesis in vivo in human breast cancer and melanoma. Blood 1996, 88:514
60. Drake TA, Cheng J, Chang A, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993, 142:1458-1470
61. Rickles FR, Levine M, Edwards RL: Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992, 11:237-248
62. Shoji M, Abe K, Nawroth PP, Rickles FR: Molecular mechanisms linking thrombosis and angiogenesis in cancer. Trends Cardiovasc Med 1997, 7:52-59